Nicholas Cross

Chairman at

Accession Therapeutics Limited

Health Technology

Process Industries

Profile

Nicholas Cross is the founder of Immunocore Holdings Plc, which was founded in 2008.
He is currently the Executive Chairman at Accession Therapeutics Limited.
Mr. Cross was formerly the Chairman at Oxford Asymmetry International Plc, Director at Avidex Ltd. from 2006 to 2008, and Non-Executive Director at Oxxon Therapeutics, Inc.

Nicholas Cross active positions

Companies	Position	Start
Accession Therapeutics Limited Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics	Chairman	-

All active positions of Nicholas Cross

Former positions of Nicholas Cross

Companies	Position	End
Avidex Ltd. Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases	Director/Board Member	2008-12-03
IMMUNOCORE HOLDINGS PLC	Founder	-
Oxford Asymmetry International Plc Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs	Chairman	-
Oxxon Therapeutics, Inc. Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients	Director/Board Member	-

See the detail of Nicholas Cross's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicholas Cross's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Oxford Asymmetry International Plc Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs	Process Industries
Avidex Ltd. Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases	Health Technology
Oxxon Therapeutics, Inc. Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients	Health Technology
Immunocore Holdings Plc Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies	Health Technology
Accession Therapeutics Limited Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics	Health Technology